Furthermore, we evaluated DFS, PFS, and DSS with TCGA database, and results suggested that tumor patients with high IMPDH1 expression usually had worse prognosis in LIHC, BLCA, CESC, KIRC KIRP, LGG, MESO, UVM (Figures S2A-Q). This evidence concerns the gene IMPDH1 and neoplasm.